Health Guide
Metabolic Health
Plain-English summaries: what it is, what it was studied for, safety and regulatory status, plus mixing and dosing charts.
6matches
9goal areas
1blends
1 Retatrutide
Most popular
An investigational once-weekly medicine from Eli Lilly that activates three hormone receptors: GIP, GLP-1 and glucagon.
2 Cagrilintide + Semaglutide (CagriSema)
Blend Most popular
An investigational combination of an amylin analogue and a GLP-1 receptor agonist.
3 AOD-9604
Most popular
A 16-amino-acid fragment of human growth hormone studied for fat metabolism.
4 Cagrilintide
An investigational long-acting amylin analogue for weight management.
5 Survodutide
An investigational once-weekly peptide that activates both GLP-1 and glucagon receptors, studied for obesity and fatty liver disease (MASH).
6 Eloralintide
An investigational once-weekly amylin receptor agonist being developed by Lilly for obesity.
Educational information only. This content summarizes published research for general education. It is not medical advice, not a recommendation to use any substance, and not an instruction for human or animal use. It does not describe any Research Product sold on this site.